tiprankstipranks
TG Therapeutics (TGTX)
:TGTX
US Market

TG Therapeutics (TGTX) Income Statement

Compare
1,911 Followers

TG Therapeutics Income Statement

Last quarter (Q3 2024), TG Therapeutics's total revenue was $83.88M, a decrease of -49.41% from the same quarter last year. In Q3, TG Therapeutics's net income was $3.88M. See TG Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 233.66M$ 2.79M$ 6.69M$ 152.00K$ 152.00K
Gross Profit
$ 219.11M$ 2.52M$ 5.90M$ -222.00K$ -130.00K
Operating Expenses
$ 198.90M$ 195.36M$ 350.67M$ 273.75M$ 169.21M
Depreciation and Amortization
$ 423.00K$ 515.00K$ 494.00K$ 374.00K$ 282.00K
EBITDA
$ 26.10M$ -187.63M$ -341.97M$ -272.68M$ -168.50M
Operating Income
$ 20.63M$ -192.84M$ -344.77M$ -273.59M$ -169.06M
Other Income/Expenses
$ -7.57M$ -5.50M$ -3.33M$ -5.79M$ -3.82M
Pretax Income
$ 13.06M$ -198.34M$ -348.10M$ -279.38M$ -172.87M
Net Income
$ 12.67M$ -203.83M$ -355.55M$ -285.88M$ -179.35M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.09$ -1.51$ -2.69$ -2.48$ -2.03
Diluted EPS
$ 0.09$ -1.51$ -2.69$ -2.48$ -2.03
Weighted Average Shares Outstanding
141.96M 135.41M 132.22M 115.33M 88.37M
Weighted Average Shares Outstanding (Diluted)
148.51M 135.41M 132.22M 115.33M 88.37M
Currency in USD

TG Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis